| Price | 57.00p on 14-01-2026 at 17:30:05 |
|---|---|
| Change | 2.50p 4.59% |
| Buy | 59.00p |
| Sell | 55.00p |
| Last Trade: | Unknown 5,000.00 at 57.00p |
| Day's Volume: | 2,251,344 |
| Last Close: | 57.00p |
| Open: | 54.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 52.00p - 58.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £247.19m |
| VWAP: | 54.53066p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 5,000 | 57.00p | OTC Trade |
17:07:11 - 14-Jan-26 |
| Sell* | 37,125 | 56.6001p | Ordinary |
16:29:38 - 14-Jan-26 |
| Buy* | 2,000 | 57.1971p | Ordinary |
16:29:03 - 14-Jan-26 |
| Buy* | 2,000 | 57.1971p | Ordinary |
16:22:57 - 14-Jan-26 |
| Sell* | 8,858 | 56.55p | Ordinary |
16:15:32 - 14-Jan-26 |
| Sell* | 8,866 | 56.5001p | Ordinary |
16:13:52 - 14-Jan-26 |
| Buy* | 17,482 | 57.20p | Ordinary |
16:10:49 - 14-Jan-26 |
| Buy* | 8,720 | 57.20p | Ordinary |
16:10:42 - 14-Jan-26 |
| Buy* | 731 | 57.2471p | Ordinary |
16:03:49 - 14-Jan-26 |
| Buy* | 1,000 | 57.2471p | Ordinary |
16:03:40 - 14-Jan-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Dec 2025 7:00 am | RNS-R | Avacta reports new AVA6103 pharmacology data |
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
